{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:00:26Z","timestamp":1790773226850,"version":"4.1.0"},"reference-count":295,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.neuroscience.2026.08.039","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:57:38Z","timestamp":1787673458000},"page":"102-119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Targeting glioblastoma epigenetics: mechanisms, microenvironmental interplay, and therapeutic potential"],"prefix":"10.1016","volume":"615","author":[{"given":"Swapnil","family":"Raut","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4302-9300","authenticated-orcid":false,"given":"Lokesh Kumar","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2026.08.039_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e27329","article-title":"Tumor-infiltrating CD8+ sub-populations in primary and recurrent glioblastoma: an in-silico study","volume":"10","author":"Abdoli Shadbad","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0010","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2176\/nmc.ra.2018-0044","article-title":"MGMT expression contributes to temozolomide resistance in H3K27M-mutant diffuse midline gliomas and MGMT silencing to temozolomide sensitivity in IDH-mutant gliomas","volume":"58","author":"Abe","year":"2018","journal-title":"Neurol. Med. Chir. (Tokyo)"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0015","doi-asserted-by":"crossref","unstructured":"Alam MA, Datta PK (2019) Epigenetic Regulation of Excitatory Amino Acid Transporter 2 in Neurological Disorders. Front Pharmacol 10 Available at: https:\/\/www.frontiersin.org\/journals\/pharmacology\/articles\/10.3389\/fphar.2019.01510\/full [Accessed April 9, 2026].","DOI":"10.3389\/fphar.2019.01510"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0020","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/cam4.3583","article-title":"A phase 1 study of combined guadecitabine and cisplatin in platinum refractory germ cell cancer","volume":"10","author":"Albany","year":"2021","journal-title":"Cancer Med."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0025","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1093\/neuonc\/not088","article-title":"Biomarker-based adaptive trials for patients with glioblastoma\u2014lessons from I-SPY 2","volume":"15","author":"Alexander","year":"2013","journal-title":"Neuro-Oncol"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0030","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9157370","article-title":"MicroRNA regulation of glycolytic metabolism in glioblastoma","volume":"2017","author":"Alfardus","year":"2017","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0035","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4103\/ATMR.ATMR_60_25","article-title":"Biomarker-guided dynamic liquid biopsy system for enhanced detection of glioblastoma recurrence via blood\u2013brain barrier permeability optimisation","volume":"2","author":"Almutairi","year":"2025","journal-title":"J Adv Trends Med Res"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0040","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00281-022-00966-0","article-title":"Tumor microenvironment antigens","volume":"45","author":"Andersen","year":"2023","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0045","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1186\/s13046-022-02529-5","article-title":"Landscape of immune-related signatures induced by targeting of different epigenetic regulators in melanoma: implications for immunotherapy","volume":"41","author":"Anichini","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0060","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/JLB.5MIR0917-351R","article-title":"IFN-\u03b3 orchestrates tumor elimination, tumor dormancy, tumor escape, and progression","volume":"103","author":"Aqbi","year":"2018","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0065","doi-asserted-by":"crossref","first-page":"5842","DOI":"10.7150\/thno.26888","article-title":"Arg1 expression defines immunosuppressive subsets of tumor-associated macrophages","volume":"8","author":"Arlauckas","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0070","doi-asserted-by":"crossref","unstructured":"Arrieta VA, Dmello C, McGrail DJ, Brat DJ, Lee-Chang C, Heimberger AB, Chand D, Stupp R, Sonabend AM (2023) Immune checkpoint blockade in glioblastoma: from tumor heterogeneity to personalized treatment. J Clin Invest 133 Available at: https:\/\/www.jci.org\/articles\/view\/163447 [Accessed July 27, 2026].","DOI":"10.1172\/JCI163447"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0075","doi-asserted-by":"crossref","first-page":"11069","DOI":"10.2147\/OTT.S230963","article-title":"miR-451: a novel biomarker and potential therapeutic target for cancer","volume":"12","author":"Bai","year":"2019","journal-title":"OncoTargets Ther"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0080","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/13543784.2019.1583742","article-title":"RX-3117 (fluorocyclopentenyl cytosine): a novel specific antimetabolite for selective cancer treatment","volume":"28","author":"Balboni","year":"2019","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0085","doi-asserted-by":"crossref","unstructured":"Bale TA, Mellinghoff IK, Graham MS (2025) Chapter Four - Liquid biopsy in the diagnosis of primary brain tumors. In: Primary Brain Tumors in Adults: Advances in Mechanistic Understanding, Evaluation, and Management (Daras M, Limbrick DD, Fisher PB, eds), pp 81\u2013102 Advances in Cancer Research. Academic Press. Available at: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0065230X25000120 [Accessed July 28, 2026].","DOI":"10.1016\/bs.acr.2025.05.004"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0090","doi-asserted-by":"crossref","first-page":"18406","DOI":"10.1074\/jbc.REV120.011202","article-title":"Structure, mechanism, and regulation of mitochondrial DNA transcription initiation","volume":"295","author":"Basu","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0095","doi-asserted-by":"crossref","first-page":"E14","DOI":"10.3171\/2022.9.FOCUS22430","article-title":"Strategies, considerations, and recent advancements in the development of liquid biopsy for glioblastoma: a step towards individualized medicine in GBM","volume":"53","author":"Bauman","year":"2022","journal-title":"Neurosurg. Focus"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0100","doi-asserted-by":"crossref","DOI":"10.1200\/JCO-25-02735","article-title":"Temozolomide versus radiotherapy as first-line therapy for low-grade glioma: mature results of a randomized phase III trial (EORTC 22033-26033\/NCIC-CTG\/TROG\/MRC-CTU)","author":"Baumert","year":"2026","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0105","first-page":"1210","article-title":"Decreased affinity for efflux transporters increases brain penetrance and molecular targeting of a PI3K\/mTOR inhibitor in a mouse model of glioblastoma","volume":"17","author":"Becker","year":"2015","journal-title":"Neuro-Oncol"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0110","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.cytogfr.2017.04.003","article-title":"Dysfunctional T cell metabolism in the tumor microenvironment","volume":"35","author":"Beckermann","year":"2017","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0115","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.cmet.2011.08.016","article-title":"Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation","volume":"14","author":"B\u00e9langer","year":"2011","journal-title":"Cell Metab."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0120","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1093\/brain\/awad195","article-title":"The coming of age of liquid biopsy in neuro-oncology","volume":"146","author":"Berzero","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0125","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1158\/0008-5472.CAN-21-3534","article-title":"Glioblastoma: the current state of biology and therapeutic strategies","volume":"82","author":"Binder","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0130","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/glia.23520","article-title":"Astrocytes, the rising stars of the glioblastoma microenvironment","volume":"67","author":"Brandao","year":"2019","journal-title":"Glia"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0135","doi-asserted-by":"crossref","unstructured":"Bruce KD, Zsombok A, Eckel RH (2017) Lipid Processing in the Brain: A Key Regulator of Systemic Metabolism. Front Endocrinol 8 Available at: https:\/\/www.frontiersin.org\/journals\/endocrinology\/articles\/10.3389\/fendo.2017.00060\/full [Accessed December 6, 2024].","DOI":"10.3389\/fendo.2017.00060"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0140","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/bph.14545","article-title":"Harnessing stem cells and biomaterials to promote neural repair","volume":"176","author":"Bruggeman","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0145","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3390\/cells10010124","article-title":"Arginine methylation in brain tumors: tumor biology and therapeutic strategies","volume":"10","author":"Bryant","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0150","doi-asserted-by":"crossref","unstructured":"Budnick HC, Richardson AM, Shiue K, Watson G, Ng SK, Le Y, Shah MV (2021) GammaTile for Gliomas: A Single-Center Case Series. Cureus Available at: https:\/\/www.cureus.com\/articles\/76420-gammatile-for-gliomas-a-single-center-case-series [Accessed July 26, 2026].","DOI":"10.7759\/cureus.19390"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0155","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1186\/s12967-025-06767-x","article-title":"DNA methylation remodeling in temozolomide resistant recurrent glioblastoma: comparing epigenetic dynamics in vitro and in vivo","volume":"23","author":"Buonaiuto","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0160","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.semcancer.2024.04.003","article-title":"Extracellular vesicles in glioblastoma: biomarkers and therapeutic tools","volume":"101","author":"Cela","year":"2024","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0165","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3389\/fnmol.2019.00065","article-title":"Dexamethasone in glioblastoma multiforme therapy: mechanisms and controversies","volume":"12","author":"Cenciarini","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0170","first-page":"592","article-title":"Plasma and cerebrospinal fluid pharmacokinetics of 5-Aza-2\u2032-deoxycytidine in rabbits and dogs1","volume":"43","author":"Chabot","year":"1983","journal-title":"Cancer Res."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0175","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.cell.2013.05.016","article-title":"Posttranscriptional control of T cell effector function by aerobic glycolysis","volume":"153","author":"Chang","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0180","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.canlet.2021.04.020","article-title":"METTL3 enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-\u03baB to promote the malignant progression of IDH-wildtype glioma","volume":"511","author":"Chang","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0185","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1053\/j.gastro.2022.06.024","article-title":"METTL3 inhibits antitumor immunity by targeting m6A-BHLHE41-CXCL1\/CXCR2 axis to promote colorectal cancer","volume":"163","author":"Chen","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0190","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41389-022-00413-7","article-title":"MicroRNA-21 is immunosuppressive and pro-metastatic via separate mechanisms","volume":"11","author":"Chi","year":"2022","journal-title":"Oncogenesis"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0195","doi-asserted-by":"crossref","first-page":"959","DOI":"10.3390\/jcm8070959","article-title":"Preclinical evidence of STAT3 inhibitor pacritinib overcoming temozolomide resistance via downregulating miR-21-enriched exosomes from M2 glioblastoma-associated macrophages","volume":"8","author":"Chuang","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0200","doi-asserted-by":"crossref","unstructured":"Cirigliano SM, Singhania R, Nicholson J, Monga I, Wan Y, Haywood C, Muley A, Giacobetti S, Fine HA (2025) Targeting Glioblastoma Cell State Plasticity for Enhanced Therapeutic Efficacy. :2025.09.08.674897 Available at: https:\/\/www.biorxiv.org\/content\/10.1101\/2025.09.08.674897v2 [Accessed July 26, 2026].","DOI":"10.1101\/2025.09.08.674897"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0205","doi-asserted-by":"crossref","first-page":"15812","DOI":"10.3390\/ijms242115812","article-title":"The hyaluronan\/CD44 axis: a double-edged sword in cancer","volume":"24","author":"Cirillo","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0210","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41591-018-0337-7","article-title":"Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma","volume":"25","author":"Cloughesy","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0215","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5728438","article-title":"Glioma stem cells and their microenvironments: providers of challenging therapeutic targets","volume":"2016","author":"Codrici","year":"2016","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0220","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.molimm.2019.12.012","article-title":"Myeloid-driven mechanisms as barriers to antitumor CD8+ T cell activity","volume":"118","author":"Colligan","year":"2020","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0225","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/bjc.2012.361","article-title":"Epigenetic remodelling of gene expression profiles of neoplastic and normal tissues: immunotherapeutic implications","volume":"107","author":"Coral","year":"2012","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0230","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1016\/j.jid.2021.04.023","article-title":"Jak-STAT inhibition mediates romidepsin and mechlorethamine synergism in cutaneous T-cell lymphoma","volume":"141","author":"Cortes","year":"2021","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0235","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cbpa.2020.04.008","article-title":"Towards a more precise therapy in cancer: exploring epigenetic complexity","volume":"57","author":"Coss\u00edo","year":"2020","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0240","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1019978","article-title":"Antitumor activity of epigenetic immunomodulation combined with CTLA-4 blockade in syngeneic mouse models","volume":"4","author":"Covre","year":"2015","journal-title":"OncoImmunology"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0245","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/neuonc\/nop009","article-title":"TGF-\u03b2 downregulates the activating receptor NKG2D on NK cells and CD8+ T cells in glioma patients","volume":"12","author":"Crane","year":"2010","journal-title":"Neuro-Oncol"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0250","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a020412","article-title":"The blood\u2013brain barrier","volume":"7","author":"Daneman","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0255","doi-asserted-by":"crossref","first-page":"658","DOI":"10.3390\/biom15050658","article-title":"Liquid biopsy-derived tumor biomarkers for clinical applications in glioblastoma","volume":"15","author":"de Lima","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0260","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/jcp.21678","article-title":"Epigenetic control","volume":"219","author":"Delcuve","year":"2009","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0265","doi-asserted-by":"crossref","first-page":"4460","DOI":"10.3390\/ijms22094460","article-title":"Altered metabolism in glioblastoma: myeloid-derived suppressor cell (MDSC) fitness and tumor-infiltrating lymphocyte (TIL) dysfunction","volume":"22","author":"Di Ianni","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0270","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3390\/genes8100240","article-title":"Extracellular vesicle-associated RNA as a carrier of epigenetic information","volume":"8","author":"Di Liegro","year":"2017","journal-title":"Genes"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0275","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12987-024-00590-0","article-title":"Blood-brain barrier permeability increases with the differentiation of glioblastoma cells in vitro","volume":"21","author":"Digiovanni","year":"2024","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0280","doi-asserted-by":"crossref","first-page":"5876","DOI":"10.1158\/0008-5472.CAN-21-1456","article-title":"ALKBH5 facilitates hypoxia-induced paraspeckle assembly and IL8 secretion to generate an immunosuppressive tumor microenvironment","volume":"81","author":"Dong","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0285","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.semcancer.2018.09.002","article-title":"Epigenetic modulation of metabolism in glioblastoma","volume":"57","author":"Dong","year":"2019","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0290","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3390\/cancers12030736","article-title":"The emerging roles of RNA modifications in glioblastoma","volume":"12","author":"Dong","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0295","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1186\/1471-2164-11-701","article-title":"DNA methylation in glioblastoma: impact on gene expression and clinical outcome","volume":"11","author":"Etcheverry","year":"2010","journal-title":"BMC Genomics"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0300","doi-asserted-by":"crossref","unstructured":"Fan W, Qi Y, Wang Y, Yan H, Li X, Zhang Y (2023) Messenger roles of extracellular vesicles during fertilization of gametes, development and implantation: Recent advances. Front Cell Dev Biol 10 Available at: https:\/\/www.frontiersin.org\/journals\/cell-and-developmental-biology\/articles\/10.3389\/fcell.2022.1079387\/full [Accessed November 5, 2025].","DOI":"10.3389\/fcell.2022.1079387"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0305","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41467-020-20379-7","article-title":"EGFR\/SRC\/ERK-stabilized YTHDF2 promotes cholesterol dysregulation and invasive growth of glioblastoma","volume":"12","author":"Fang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0310","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.2147\/IJN.S231479","article-title":"Overcoming the blood\u2013brain barrier: successes and challenges indeveloping nanoparticle-mediated drug delivery systems for the treatment of brain tumours","volume":"15","author":"Ferraris","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0315","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/43710","article-title":"Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors","volume":"401","author":"Finnin","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0320","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3390\/biology13120967","article-title":"Unveiling the tumor microenvironment through fibroblast activation protein targeting in diagnostic nuclear medicine: a didactic review on biological rationales and key imaging agents","volume":"13","author":"Fouillet","year":"2024","journal-title":"Biology"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0325","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1158\/2326-6066.CIR-17-0080","article-title":"Antitumor effects of Epidrug\/IFN\u03b1 combination driven by modulated gene signatures in both colorectal cancer and dendritic cells","volume":"5","author":"Fragale","year":"2017","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0330","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1148\/radiol.11103503","article-title":"Improved perfusion MR imaging assessment of intracerebral tumor blood volume and antiangiogenic therapy efficacy in a rat model with ferumoxytol","volume":"261","author":"Gahramanov","year":"2011","journal-title":"Radiology"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0335","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s11060-020-03461-4","article-title":"Epigenetic preconditioning with decitabine sensitizes glioblastoma to temozolomide via induction of MLH1","volume":"147","author":"Gallitto","year":"2020","journal-title":"J. Neurooncol"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0340","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40364-018-0122-2","article-title":"Epigenetic regulation of cancer progression by EZH2: from biological insights to therapeutic potential","volume":"6","author":"Gan","year":"2018","journal-title":"Biomark Res"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0345","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13148-019-0776-0","article-title":"The timeline of epigenetic drug discovery: from reality to dreams","volume":"11","author":"Ganesan","year":"2019","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0350","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1215\/15228517-2006-024","article-title":"The impact of thrombocytopenia from temozolomide and radiation in newly diagnosed adults with high-grade gliomas1","volume":"9","author":"Gerber","year":"2007","journal-title":"Neuro-Oncol"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0355","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12964-020-00623-9","article-title":"Role of exosomes in malignant glioma: microRNAs and proteins in pathogenesis and diagnosis","volume":"18","author":"Ghaemmaghami","year":"2020","journal-title":"Cell Commun Signal CCS"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0360","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13578-022-00771-0","article-title":"DNA in extracellular vesicles: from evolution to its current application in health and disease","volume":"12","author":"Ghanam","year":"2022","journal-title":"Cell Biosci."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0365","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.3390\/ijms20061291","article-title":"Revisiting histone deacetylases in human tumorigenesis: the paradigm of urothelial bladder cancer","volume":"20","author":"Giannopoulou","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0370","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/neuonc\/4.4.261","article-title":"A phase II study of temozolomide in patients with newly diagnosed supratentorial malignant glioma before radiation therapy","volume":"4","author":"Gilbert","year":"2002","journal-title":"Neuro-Oncol"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0375","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1154753","article-title":"Mitoepigenetics and gliomas: epigenetic alterations to mitochondrial DNA and nuclear DNA alter mtDNA expression and contribute to glioma pathogenicity","volume":"14","author":"Grady","year":"2023","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0380","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1016\/j.biochi.2012.07.025","article-title":"DNA methylation inhibitors in cancer: recent and future approaches","volume":"94","author":"Gros","year":"2012","journal-title":"Biochimie"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0385","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1158\/1078-0432.CCR-09-3106","article-title":"Survival of patients with newly diagnosed glioblastoma treated with radiation and temozolomide on research studies in the United States","volume":"16","author":"Grossman","year":"2010","journal-title":"Clin Cancer Res off J Am Assoc Cancer Res"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0395","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.neuron.2019.08.028","article-title":"Microglia\/brain macrophages as central drivers of brain tumor pathobiology","volume":"104","author":"Gutmann","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0400","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40478-024-01750-x","article-title":"DNA hypomethylator phenotype reprograms glutamatergic network in receptor tyrosine kinase gene-mutated glioblastoma","volume":"12","author":"Harachi","year":"2024","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0405","doi-asserted-by":"crossref","DOI":"10.1200\/PO-25-00518","article-title":"Use of protein arginine methyltransferase inhibitors in gliomas","author":"Harbi","year":"2025","journal-title":"JCO Precis. Oncol.."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0410","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.3390\/cells12121578","article-title":"A comprehensive review of mirnas and their epigenetic effects in glioblastoma","volume":"12","author":"Hasan","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0415","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.2147\/CMAR.S186142","article-title":"The unique invasiveness of glioblastoma and possible drug targets on extracellular matrix","volume":"11","author":"Hatoum","year":"2019","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0420","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020105977","article-title":"m6A RNA methylation: from mechanisms to therapeutic potential","volume":"40","author":"He","year":"2021","journal-title":"EMBO J."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0425","doi-asserted-by":"crossref","unstructured":"He Y, Song W, Li S, Guo J (2026) The glioblastoma ecosystem: clonal evolution, heterogeneity, and therapeutic resistance. Front Cell Dev Biol 14 Available at: https:\/\/www.frontiersin.org\/journals\/cell-and-developmental-biology\/articles\/10.3389\/fcell.2026.1834106\/full [Accessed July 26, 2026].","DOI":"10.3389\/fcell.2026.1834106"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0430","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.3390\/cells10123529","article-title":"Glioblastoma: relationship between metabolism and immunosuppressive microenvironment","volume":"10","author":"Hern\u00e1ndez","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0435","unstructured":"Hodroj Z, Rizk M, Nabha R, Nasrallah K (2023) SOX2 in Glioblastoma: Regulation Mechanisms and A Potential Therapeutic Target. J Surg Available at: https:\/\/www.gavinpublishers.com\/article\/view\/sox2-in-glioblastoma-regulation-mechanisms-and-a-potential-therapeutic-target [Accessed April 14, 2026]."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0440","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11060-019-03274-0","article-title":"The protein arginine methyltransferase PRMT5 confers therapeutic resistance to mTOR inhibition in glioblastoma","volume":"145","author":"Holmes","year":"2019","journal-title":"J. Neurooncol"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0445","doi-asserted-by":"crossref","first-page":"9687","DOI":"10.7150\/thno.60851","article-title":"Inhibition of tumor progression and M2 microglial polarization by extracellular vesicle-mediated microRNA-124 in a 3D microfluidic glioblastoma microenvironment","volume":"11","author":"Hong","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0450","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2019.1670893","article-title":"Degradation of tumour stromal hyaluronan by small extracellular vesicle-PH20 stimulates CD103+ dendritic cells and in combination with PD-L1 blockade boosts anti-tumour immunity","volume":"8","author":"Hong","year":"2019","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0455","article-title":"Challenges and advances for glioma therapy based on inorganic nanoparticles","volume":"20","author":"Hu","year":"2023","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0460","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.7150\/ijbs.83531","article-title":"The evolution of tumor microenvironment in gliomas and its implication for target therapy","volume":"19","author":"Hu","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0465","doi-asserted-by":"crossref","unstructured":"Iglesia RP, Fernandes CF de L, Coelho BP, Prado MB, Melo Escobar MI, Almeida GHDR, Lopes MH (2019) Heat Shock Proteins in Glioblastoma Biology: Where Do We Stand? Int J Mol Sci 20:5794.","DOI":"10.3390\/ijms20225794"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0470","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3390\/cancers6010226","article-title":"Glioblastoma multiforme: a look inside its heterogeneous nature","volume":"6","author":"Inda","year":"2014","journal-title":"Cancers"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0475","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1158\/1078-0432.CCR-20-2291","article-title":"Concurrent dexamethasone limits the clinical benefit of immune checkpoint blockade in glioblastoma","volume":"27","author":"Iorgulescu","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0480","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3390\/cells7080093","article-title":"The role of extracellular vesicles in cancer: cargo, function, and therapeutic implications","volume":"7","author":"Jabalee","year":"2018","journal-title":"Cells"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0485","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.3390\/cancers11081207","article-title":"Tumor cell dormancy: threat or opportunity in the fight against cancer","volume":"11","author":"Jahanban-Esfahlan","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106327","article-title":"Metabolic remodeling in astrocytes: paving the path to brain tumor development","volume":"188","author":"Jara\u00edz-Rodr\u00edguez","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0495","doi-asserted-by":"crossref","unstructured":"Jayasinghe R, Danushka N (2025) Astrocytes in Glioblastoma Therapy: A Novel Approach to Targeting Tumor Microenvironment. In: Glioblastoma - New Solutions for Brain Cancerogenesis. IntechOpen. Available at: https:\/\/www.intechopen.com\/chapters\/1208684 [Accessed April 14, 2026].","DOI":"10.5772\/intechopen.1008927"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0500","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.tcb.2014.07.003","article-title":"Adult neurogenesis: bridging the gap between mice and humans","volume":"24","author":"Jessberger","year":"2014","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0505","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1080\/21645515.2019.1571892","article-title":"PD-1 and PD-L1 in cancer immunotherapy: clinical implications and future considerations","volume":"15","author":"Jiang","year":"2019","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0510","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1038\/nm.4415","article-title":"Targeting glioma stem cells through combined BMI1 and EZH2 inhibition","volume":"23","author":"Jin","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0515","doi-asserted-by":"crossref","unstructured":"Johnson AL, Laterra J, Lopez-Bertoni H (2022) Exploring glioblastoma stem cell heterogeneity: Immune microenvironment modulation and therapeutic opportunities. Front Oncol 12 Available at: https:\/\/www.frontiersin.org\/journals\/oncology\/articles\/10.3389\/fonc.2022.995498\/full [Accessed December 6, 2024].","DOI":"10.3389\/fonc.2022.995498"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0520","doi-asserted-by":"crossref","first-page":"654","DOI":"10.3390\/biomedicines11030654","article-title":"Epigenetic regulators of DNA cytosine modification: promising targets for cancer therapy","volume":"11","author":"Jung","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0525","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.bbadis.2015.10.026","article-title":"Signal transduction and epigenetic mechanisms in the control of microglia activation during neuroinflammation","volume":"1862","author":"Kaminska","year":"2016","journal-title":"Biochim Biophys Acta BBA - Mol Basis Dis"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0530","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.705580","article-title":"Optimizing T cell-based therapy for glioblastoma","volume":"12","author":"Karachi","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0535","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.bbcan.2016.04.001","article-title":"Epigenetic silencing of tumor suppressor genes: paradigms, puzzles, and potential","volume":"1865","author":"Kazanets","year":"2016","journal-title":"Biochim Biophys Acta BBA - Rev Cancer"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0540","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1528-1167.2012.03701.x","article-title":"Blood\u2013brain barrier dysfunction\u2013induced inflammatory signaling in brain pathology and epileptogenesis","volume":"53","author":"Kim","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0545","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1215\/15228517-2008-090","article-title":"Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts","volume":"11","author":"Kitange","year":"2009","journal-title":"Neuro-Oncol"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0550","doi-asserted-by":"crossref","first-page":"6136","DOI":"10.1038\/s41598-019-42237-3","article-title":"Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cells","volume":"9","author":"Knox","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0555","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1586\/ern.13.7","article-title":"Pseudoprogression after glioma therapy: a comprehensive review","volume":"13","author":"Kruser","year":"2013","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0560","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116740","article-title":"Global profiling of metabolic adaptation to hypoxic stress in human glioblastoma cells","volume":"10","author":"Kucharzewska","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0565","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.ijrobp.2021.03.032","article-title":"Initial results of a phase 2 trial of 18F-DOPA PET-guided dose-escalated radiation therapy for glioblastoma","volume":"110","author":"Laack","year":"2021","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0570","doi-asserted-by":"crossref","DOI":"10.1242\/dev.200270","article-title":"Biology of resident tissue macrophages","volume":"149","author":"Lee","year":"2022","journal-title":"Development"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0575","doi-asserted-by":"crossref","first-page":"e553","DOI":"10.1002\/ctm2.553","article-title":"Interplay of m6A and histone modifications contributes to temozolomide resistance in glioblastoma","volume":"11","author":"Li","year":"2021","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0580","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3390\/pharmaceutics16070865","article-title":"Immunotherapies targeting tumor-associated macrophages (TAMs) in cancer","volume":"16","author":"Li","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0585","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3390\/biomedicines13010210","article-title":"Comprehensive overview of ketone bodies in cancer metabolism: mechanisms and application","volume":"13","author":"Liang","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0590","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/s41419-022-05389-1","article-title":"PRMT3 drives glioblastoma progression by enhancing HIF1A and glycolytic metabolism","volume":"13","author":"Liao","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0595","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12943-024-02023-w","article-title":"Regulatory mechanisms of PD-1\/PD-L1 in cancers","volume":"23","author":"Lin","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0600","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/j.apsb.2021.12.019","article-title":"Therapeutic strategies of glioblastoma (GBM): the current advances in the molecular targets and bioactive small molecule compounds","volume":"12","author":"Liu","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0605","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114619","article-title":"Strategies to overcome\/penetrate the BBB for systemic nanoparticle delivery to the brain\/brain tumor","volume":"191","author":"Liu","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0610","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.molmed.2024.02.004","article-title":"Epigenetic regulation of tumor-immune symbiosis in glioma","volume":"30","author":"Liu","year":"2024","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0615","first-page":"1","article-title":"The diversified role of mitochondria in ferroptosis in cancer","volume":"14","author":"Liu","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0620","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1038\/s41423-024-01226-x","article-title":"Immunotherapy for glioblastoma: current state, challenges, and future perspectives","volume":"21","author":"Liu","year":"2024","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0625","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3390\/pharmaceutics13010073","article-title":"Targeting germ cell tumors with the newly synthesized flavanone-derived compound MLo1302 efficiently reduces tumor cell viability and induces apoptosis and cell cycle arrest","volume":"13","author":"Lobo","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0635","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41392-021-00857-0","article-title":"Sox2 induces glioblastoma cell stemness and tumor propagation by repressing TET2 and deregulating 5hmC and 5mC DNA modifications","volume":"7","author":"Lopez-Bertoni","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0640","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature14432","article-title":"Structural and functional features of central nervous system lymphatic vessels","volume":"523","author":"Louveau","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0645","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12943-020-01197-3","article-title":"Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy","volume":"19","author":"Lu","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0650","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12865-020-0337-5","article-title":"The DNA methyltransferase inhibitor, guadecitabine, targets tumor-induced myelopoiesis and recovers T cell activity to slow tumor growth in combination with adoptive immunotherapy in a mouse model of breast cancer","volume":"21","author":"Luker","year":"2020","journal-title":"BMC Immunol."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0655","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41467-017-02630-w","article-title":"DNA methyltransferase inhibition upregulates MHC-I to potentiate cytotoxic T lymphocyte responses in breast cancer","volume":"9","author":"Luo","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0660","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.devcel.2022.05.007","article-title":"PDGF signaling inhibits mitophagy in glioblastoma stem cells through N6-methyladenosine","volume":"57","author":"Lv","year":"2022","journal-title":"Dev. Cell"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0665","doi-asserted-by":"crossref","first-page":"6190","DOI":"10.1158\/0008-5472.CAN-17-1388","article-title":"Histone acetyltransferase KAT6A upregulates PI3K\/AKT signaling through TRIM24 binding","volume":"77","author":"Lv","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0670","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.1016\/j.molcel.2023.10.025","article-title":"EGFR promotes ALKBH5 nuclear retention to attenuate N6-methyladenosine and protect against ferroptosis in glioblastoma","volume":"83","author":"Lv","year":"2023","journal-title":"Mol. Cell"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0675","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1093\/neuonc\/noac107","article-title":"Decitabine increases neoantigen and cancer testis antigen expression to enhance T-cell\u2013mediated toxicity against glioblastoma","volume":"24","author":"Ma","year":"2022","journal-title":"Neuro-Oncol"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0680","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ccell.2017.08.017","article-title":"Integrated molecular meta-analysis of 1,000 pediatric high-grade and diffuse intrinsic pontine glioma","volume":"32","author":"Mackay","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0685","doi-asserted-by":"crossref","first-page":"7017","DOI":"10.4049\/jimmunol.165.12.7017","article-title":"Activation of MHC class I, II, and CD40 gene expression by histone deacetylase inhibitors1","volume":"165","author":"Magner","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0690","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/glia.23887","article-title":"Sequential changes in histone modifications shape transcriptional responses underlying microglia polarization by glioma","volume":"69","author":"Maleszewska","year":"2021","journal-title":"Glia"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0695","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1158\/2159-8290.CD-23-1336","article-title":"Glioblastoma cortical organoids recapitulate cell-state heterogeneity and intercellular transfer","volume":"15","author":"Mangena","year":"2025","journal-title":"Cancer Discov."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0700","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1238541","article-title":"CCL22-specific T cells: modulating the immunosuppressive tumor microenvironment","volume":"5","author":"Martinenaite","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0705","first-page":"1181","article-title":"Blood-brain barrier-associated efflux transporters: a significant but underappreciated obstacle to drug development in glioblastoma","volume":"17","author":"Mason","year":"2015","journal-title":"Neuro-Oncol"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0710","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/bpa.12307","article-title":"mTORC2 and metabolic reprogramming in GBM: at the interface of genetics and environment","volume":"25","author":"Masui","year":"2015","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0715","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13014-023-02236-1","article-title":"High-dose proton beam therapy versus conventional fractionated radiation therapy for newly diagnosed glioblastoma: a propensity score matching analysis","volume":"18","author":"Matsuda","year":"2023","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0720","doi-asserted-by":"crossref","unstructured":"Matthews GM, Newbold A, Johnstone RW (2012) Chapter Five - Intrinsic and Extrinsic Apoptotic Pathway Signaling as Determinants of Histone Deacetylase Inhibitor Antitumor Activity. In: Advances in Cancer Research (Grant S, ed), pp 165\u2013197 Histone Deacetylase Inhibitors as Cancer Therapeutics. Academic Press. Available at: https:\/\/www.sciencedirect.com\/science\/article\/pii\/B9780123943873000057 [Accessed January 14, 2025].","DOI":"10.1016\/B978-0-12-394387-3.00005-7"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0725","doi-asserted-by":"crossref","first-page":"CNS86","DOI":"10.2217\/cns-2021-0015","article-title":"Radiotherapy-drug combinations in the treatment of glioblastoma: a brief review","volume":"11","author":"McAleavey","year":"2022","journal-title":"CNS Oncol"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0730","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1144184","article-title":"The function of histone methylation and acetylation regulators in GBM pathophysiology","volume":"13","author":"McCornack","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0735","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/glia.23718","article-title":"Astrocytes enhance glioblastoma growth","volume":"68","author":"Mega","year":"2020","journal-title":"Glia"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0740","doi-asserted-by":"crossref","first-page":"5634","DOI":"10.3390\/ijms26125634","article-title":"Epigenetic alterations in glioblastoma multiforme as novel therapeutic targets: a scoping review","volume":"26","author":"Meleiro","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0745","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12575-024-00241-6","article-title":"MicroRNA nano-shuttles: engineering extracellular vesicles as a cutting-edge biotechnology platform for clinical use in therapeutics","volume":"26","author":"Menjivar","year":"2024","journal-title":"Biol. Proced. Online"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0750","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/cei.13050","article-title":"CD4+ T helper cells and regulatory T cells in active lupus nephritis: an imbalance towards a predominant Th1 response?","volume":"191","author":"Mesquita","year":"2018","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0755","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.celrep.2019.03.029","article-title":"HIF-1\u03b1 is a metabolic switch between glycolytic-driven migration and oxidative phosphorylation-driven immunosuppression of tregs in glioblastoma","volume":"27","author":"Miska","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0760","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/mmr.2025.13443","article-title":"Mitochondrial DNA copy number alterations: key players in the complexity of glioblastoma (review)","volume":"31","author":"Mohamed Yusoff","year":"2025","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0765","doi-asserted-by":"crossref","unstructured":"Monica RD, Cuomo M, Buonaiuto M, Costabile D, Franca RA, Caro MDBD, Catapano G, Chiariotti L, Visconti R (2022) MGMT and Whole-Genome DNA Methylation Impacts on Diagnosis, Prognosis and Therapy of Glioblastoma Multiforme. Int J Mol Sci 23 Available at: https:\/\/www.mdpi.com\/1422-0067\/23\/13\/7148 [Accessed April 4, 2026].","DOI":"10.3390\/ijms23137148"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0770","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3390\/biology14070749","article-title":"Multi-faceted role of histone methyltransferase enhancer of Zeste 2 (EZH2) in neuroinflammation and emerging targeting options","volume":"14","author":"Moraitis","year":"2025","journal-title":"Biology"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0775","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/cbin.70005","article-title":"Role of glutamate excitotoxicity in glioblastoma growth and its implications in treatment","volume":"49","author":"Moriarty","year":"2025","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0780","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2025.1541885","article-title":"Tight junction proteins in glial tumors development and progression","volume":"19","author":"Moskal","year":"2025","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0785","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/cncr.25637","article-title":"Benefits of interferon-\u03b2 and temozolomide combination therapy for newly diagnosed primary glioblastoma with the unmethylated MGMT promoter: a multicenter study","volume":"117","author":"Motomura","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0790","doi-asserted-by":"crossref","first-page":"8682","DOI":"10.3390\/ijms21228682","article-title":"The role of extracellular vesicles (EVs) in the epigenetic regulation of bone metabolism and osteoporosis","volume":"21","author":"Muraca","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0795","doi-asserted-by":"crossref","unstructured":"Musatova OE, Rubtsov YP (2023) Effects of glioblastoma-derived extracellular vesicles on the functions of immune cells. Front Cell Dev Biol 11 Available at: https:\/\/www.frontiersin.org\/journals\/cell-and-developmental-biology\/articles\/10.3389\/fcell.2023.1060000\/full [Accessed November 5, 2025].","DOI":"10.3389\/fcell.2023.1060000"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0800","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3389\/fonc.2012.00098","article-title":"The strategy for enhancing temozolomide against malignant glioma","volume":"2","author":"Nakada","year":"2012","journal-title":"Front. Oncol."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0805","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1182\/bloodadvances.2018027672","article-title":"MYD88 L265P mutation and CDKN2A loss are early mutational events in primary central nervous system diffuse large B-cell lymphomas","volume":"3","author":"Nayyar","year":"2019","journal-title":"Blood Adv."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0810","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1158\/1078-0432.CCR-11-1000","article-title":"Hsp90 molecular chaperone inhibitors: are we there yet?","volume":"18","author":"Neckers","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0815","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.cell.2019.06.024","article-title":"An integrative model of cellular states, plasticity, and genetics for glioblastoma","volume":"178","author":"Neftel","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0820","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2147\/LCTT.S11726","article-title":"Azacitidine and decitabine have different mechanisms of action in non-small cell lung cancer cell lines","volume":"1","author":"Nguyen","year":"2010","journal-title":"Lung Cancer Targets Ther"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0825","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.3390\/cancers18111779","article-title":"Advances in brain tumor biomarkers: from molecular profiling to liquid biopsy and AI-driven detection","volume":"18","author":"Nguyen","year":"2026","journal-title":"Cancers"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0830","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1172\/JCI129049","article-title":"HDAC inhibitors elicit metabolic reprogramming by targeting super-enhancers in glioblastoma models","volume":"130","author":"Nguyen","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0835","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.3390\/cancers16122175","article-title":"G9a in cancer: mechanisms, therapeutic advancements, and clinical implications","volume":"16","author":"Ni","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0840","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/nm.2492","article-title":"Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth","volume":"17","author":"Nieman","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0845","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41571-018-0142-8","article-title":"Cancer immunoediting and resistance to T cell-based immunotherapy","volume":"16","author":"O\u2019Donnell","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0850","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.molmed.2014.10.009","article-title":"Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway","volume":"21","author":"Ohaegbulam","year":"2015","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0855","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1513073","article-title":"Targeted detection of sequence variants in cell-free DNA from cerebrospinal fluid in pediatric central nervous system tumors","volume":"14","author":"O\u2019Halloran","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0860","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.semcancer.2020.01.001","article-title":"Exposing hidden targets: combining epigenetic and immunotherapy to overcome cancer resistance","volume":"65","author":"Olino","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0865","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/neuonc\/noac099","article-title":"Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: an international randomized phase III trial","volume":"25","author":"Omuro","year":"2023","journal-title":"Neuro-Oncol"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0870","doi-asserted-by":"crossref","DOI":"10.1016\/j.crphar.2024.100193","article-title":"The potential of miRNA-based approaches in glioblastoma: an update in current advances and future perspectives","volume":"7","author":"Ord\u00f3\u00f1ez-Rubiano","year":"2024","journal-title":"Curr Res Pharmacol Drug Discov"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0875","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.1158\/1078-0432.CCR-17-0741","article-title":"Entinostat neutralizes myeloid-derived suppressor cells and enhances the antitumor effect of PD-1 inhibition in murine models of lung and renal cell carcinoma","volume":"23","author":"Orillion","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0880","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.574012","article-title":"A review of newly diagnosed glioblastoma","volume":"10","author":"Oronsky","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0885","doi-asserted-by":"crossref","first-page":"12669","DOI":"10.18632\/aging.102792","article-title":"Extracellular vesicles derived from microRNA-150-5p-overexpressing mesenchymal stem cells protect rat hearts against ischemia\/reperfusion","volume":"12","author":"Ou","year":"2020","journal-title":"Aging"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0890","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.3390\/cancers15041342","article-title":"DNA methylation and histone modification in low-grade gliomas: current understanding and potential clinical targets","volume":"15","author":"Ozair","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0895","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.583084","article-title":"Tumor-associated macrophages in tumor immunity","volume":"11","author":"Pan","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0900","doi-asserted-by":"crossref","first-page":"5850","DOI":"10.1158\/1078-0432.CCR-18-1345","article-title":"Clinically relevant and minimally invasive tumor surveillance of pediatric diffuse midline gliomas using patient-derived liquid biopsy","volume":"24","author":"Panditharatna","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0905","doi-asserted-by":"crossref","unstructured":"Park JH, Lee HK (2022) Current Understanding of Hypoxia in Glioblastoma Multiforme and Its Response to Immunotherapy. Cancers 14 Available at: https:\/\/www.mdpi.com\/2072-6694\/14\/5\/1176 [Accessed March 28, 2026].","DOI":"10.3390\/cancers14051176"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0910","doi-asserted-by":"crossref","first-page":"11832","DOI":"10.3390\/ijms150711832","article-title":"The diagnosis and treatment of pseudoprogression, radiation necrosis and brain tumor recurrence","volume":"15","author":"Parvez","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0915","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112532","article-title":"EZH2 as a new therapeutic target in brain tumors: molecular landscape, therapeutic targeting and future prospects","volume":"146","author":"Paskeh","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0920","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111829","article-title":"Synthesis of novel 3-halo-3-nitroflavanones and their activities as DNA methyltransferase inhibitors in cancer cells","volume":"186","author":"Pechalrieu","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0925","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJMoa1611977","article-title":"Short-course radiation plus temozolomide in elderly patients with glioblastoma","volume":"376","author":"Perry","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0930","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/j.jtho.2021.06.020","article-title":"Outcomes with pembrolizumab plus platinum-based chemotherapy for patients with NSCLC and stable brain metastases: pooled analysis of KEYNOTE-021, -189, and -407","volume":"16","author":"Powell","year":"2021","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0935","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/neuonc\/noag003","article-title":"Tumor microenvironment shapes the spatial organization of glioblastoma cell states","volume":"28","author":"Prakash","year":"2026","journal-title":"Neuro-Oncol"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0940","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41392-025-02241-8","article-title":"Neuro-immune crosstalk in cancer: mechanisms and therapeutic implications","volume":"10","author":"Pu","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0945","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ccell.2017.02.009","article-title":"The microenvironmental landscape of brain tumors","volume":"31","author":"Quail","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0950","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1621812","article-title":"The tumor immune microenvironment: implications for cancer immunotherapy, treatment strategies, and monitoring approaches","volume":"16","author":"Racacho","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0955","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006127","article-title":"First-line nivolumab plus ipilimumab for metastatic non-small cell lung cancer, including patients with ECOG performance status 2 and other special populations: CheckMate 817","volume":"11","author":"Ready","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0960","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ejpb.2018.11.001","article-title":"Development of doxorubicin hydrochloride loaded pH-sensitive liposomes: investigation on the impact of chemical nature of lipids and liposome composition on pH-sensitivity","volume":"133","author":"Rehman","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0965","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113784","article-title":"Design strategies for hyaluronic acid-based drug delivery systems in cancer immunotherapy","volume":"383","author":"Rodella","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0970","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3389\/fonc.2018.00448","article-title":"Epigenetic targeting of glioblastoma","volume":"8","author":"Romani","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0975","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10014-016-0259-3","article-title":"MicroRNA and extracellular vesicles in glioblastoma \u2013 small but powerful","volume":"33","author":"Rooj","year":"2016","journal-title":"Brain Tumor Pathol."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0980","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1158\/0008-5472.CAN-16-0834","article-title":"Transcriptional selectivity of epigenetic therapy in cancer","volume":"77","author":"Sato","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.neuroscience.2026.08.039_b0985","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/oncolo\/oyac064","article-title":"Immune checkpoint inhibitors in the treatment of breast cancer brain metastases","volume":"27","author":"Schlam","year":"2022","journal-title":"Oncologist"},{"key":"10.1016\/j.neuroscience.2026.08.039_b0995","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1126\/science.1203486","article-title":"Cancer immunoediting: integrating immunity\u2019s roles in cancer suppression and promotion","volume":"331","author":"Schreiber","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2026.08.039_b1000","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s12967-024-04918-0","article-title":"Cancer testis antigen burden (CTAB): a novel biomarker of tumor-associated antigens in lung cancer","volume":"22","author":"Seager","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.neuroscience.2026.08.039_b1005","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3390\/genes13020244","article-title":"MicroRNA interrelated epithelial mesenchymal transition (EMT) in glioblastoma","volume":"13","author":"Setlai","year":"2022","journal-title":"Genes"},{"key":"10.1016\/j.neuroscience.2026.08.039_b1010","article-title":"Postoperative NEOadjuvant TEMozolomide followed by chemoradiotherapy versus upfront chemoradiotherapy for glioblastoma multiforme (NEOTEM) trial: interim results","volume":"6","author":"Sharifian","year":"2024","journal-title":"Neuro-Oncol. Adv."},{"key":"10.1016\/j.neuroscience.2026.08.039_b1015","article-title":"Tumor microenvironment in glioblastoma: current and emerging concepts","volume":"5","author":"Sharma","year":"2023","journal-title":"Neuro-Oncol. Adv."},{"key":"10.1016\/j.neuroscience.2026.08.039_b1020","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1021\/acs.jmedchem.3c02053","article-title":"First-in-class dual EZH2-HSP90 inhibitor eliciting striking antiglioblastoma activity in vitro and in vivo","volume":"67","author":"Sharma","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuroscience.2026.08.039_b1025","doi-asserted-by":"crossref","unstructured":"Shi J, Chen G, Dong X, Li H, Li S, Cheng S, Li Y, Wang L, Yuan J, Qian Z, Dong J (2021) METTL3 Promotes the Resistance of Glioma to Temozolomide via Increasing MGMT and ANPG in a m6A Dependent Manner. Front Oncol 11 Available at: https:\/\/www.frontiersin.org\/journals\/oncology\/articles\/10.3389\/fonc.2021.702983\/full [Accessed April 14, 2026].","DOI":"10.3389\/fonc.2021.702983"},{"key":"10.1016\/j.neuroscience.2026.08.039_b1030","doi-asserted-by":"crossref","DOI":"10.26599\/OSHM.2026.9610044","article-title":"As 5mC enters a programmable era: charted avenues for cancer understanding and intervention","volume":"2","author":"Shi","year":"2026","journal-title":"Oral Sci Homeost Med"},{"key":"10.1016\/j.neuroscience.2026.08.039_b1035","article-title":"Research progress of HIF-1a on immunotherapy outcomes in immune vascular microenvironment","volume":"16","author":"Shi","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuroscience.2026.08.039_b1040","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1756-8722-2-31","article-title":"Vorinostat in solid and hematologic malignancies","volume":"2","author":"Siegel","year":"2009","journal-title":"J Hematol OncolJ Hematol Oncol"},{"key":"10.1016\/j.neuroscience.2026.08.039_b1045","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s12935-024-03441-y","article-title":"GLP and G9a histone methyltransferases as potential therapeutic targets for lymphoid neoplasms","volume":"24","author":"Silva-Carvalho","year":"2024","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.neuroscience.2026.08.039_b1050","doi-asserted-by":"crossref","first-page":"988","DOI":"10.3390\/pharmaceutics13070988","article-title":"The multifaceted role of extracellular vesicles in glioblastoma: microRNA nanocarriers for disease progression and gene therapy","volume":"13","author":"Simionescu","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.neuroscience.2026.08.039_b1055","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-002181","article-title":"Deep immune profiling reveals targetable mechanisms of immune evasion in immune checkpoint inhibitor-refractory glioblastoma","volume":"9","author":"Simonds","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.neuroscience.2026.08.039_b1060","article-title":"Next-generation miRNA therapeutics: from computational design to translational engineering","volume":"2025","author":"Singh","year":"2025","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.neuroscience.2026.08.039_b1065","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41392-025-02299-4","article-title":"Glioblastoma at the crossroads: current understanding and future therapeutic horizons","volume":"10","author":"Singh","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.neuroscience.2026.08.039_b1070","first-page":"5821","article-title":"Identification of a cancer stem cell in human brain tumors","volume":"63","author":"Singh","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.neuroscience.2026.08.039_b1075","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3390\/cancers17010146","article-title":"Glioblastoma: clinical presentation, multidisciplinary management, and long-term outcomes","volume":"17","author":"Sipos","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.neuroscience.2026.08.039_b1080","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41586-019-1912-x","article-title":"VEGF-C-driven lymphatic drainage enables immunosurveillance of brain tumours","volume":"577","author":"Song","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2026.08.039_b1085","article-title":"Protein arginine methyltransferase 5 as a novel therapeutic target in solid tumors","volume":"13","author":"Song","year":"2026","journal-title":"Genes Dis"},{"key":"10.1016\/j.neuroscience.2026.08.039_b1090","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/ncponc1204","article-title":"Response criteria for glioma","volume":"5","author":"Sorensen","year":"2008","journal-title":"Nat. Clin. Pract. Oncol."},{"key":"10.1016\/j.neuroscience.2026.08.039_b1095","doi-asserted-by":"crossref","first-page":"11292","DOI":"10.3390\/ijms222011292","article-title":"EHMT2\/G9a as an epigenetic target in pediatric and adult brain tumors","volume":"22","author":"Souza","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2026.08.039_b1100","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.3390\/biomedicines12112631","article-title":"The role of HDAC6 in glioblastoma multiforme: a new avenue to therapeutic interventions?","volume":"12","author":"Spallotta","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.neuroscience.2026.08.039_b1105","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12935-025-03721-1","article-title":"Amino acid metabolism in glioblastoma pathogenesis, immune evasion, and treatment resistance","volume":"25","author":"Srivastava","year":"2025","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.neuroscience.2026.08.039_b1110","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2016.1154641","article-title":"Junctional proteins of the blood-brain barrier: new insights into function and dysfunction","volume":"4","author":"Stamatovic","year":"2016","journal-title":"Tissue Barriers"},{"key":"10.1016\/j.neuroscience.2026.08.039_b1115","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.752404","article-title":"High expression of glycolytic genes in clinical glioblastoma patients correlates with lower survival","volume":"8","author":"Stanke","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.neuroscience.2026.08.039_b1120","doi-asserted-by":"crossref","unstructured":"Starck L, Sarem M, Heimrich B, Sawarkar R, Ritz M-F, Hutter G, Shastri VP (2023) Biophysical basis for the induction of glioblastoma-like phenotype in astrocytes. :2023.07.31.551259 Available at: https:\/\/www.biorxiv.org\/content\/10.1101\/2023.07.31.551259v1 [Accessed April 14, 2026].","DOI":"10.1101\/2023.07.31.551259"},{"key":"10.1016\/j.neuroscience.2026.08.039_b1125","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1093\/neuonc\/noag038","article-title":"Mitochondria transfer in glioblastoma","volume":"28","author":"Storevik","year":"2026","journal-title":"Neuro-Oncol"},{"key":"10.1016\/j.neuroscience.2026.08.039_b1130","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ijc.23607","article-title":"Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine","volume":"123","author":"Stresemann","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.neuroscience.2026.08.039_b1135","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuroscience.2026.08.039_b1140","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s42003-022-04303-x","article-title":"OxPhos defects cause hypermetabolism and reduce lifespan in cells and in patients with mitochondrial diseases","volume":"6","author":"Sturm","year":"2023","journal-title":"Commun. Biol."},{"key":"10.1016\/j.neuroscience.2026.08.039_b1145","doi-asserted-by":"crossref","first-page":"5977","DOI":"10.1093\/nar\/gky339","article-title":"Global DNA methylation synergistically regulates the nuclear and mitochondrial genomes in glioblastoma cells","volume":"46","author":"Sun","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neuroscience.2026.08.039_b1150","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/neuonc\/noad232","article-title":"Metabolic modulation of histone acetylation mediated by HMGCL activates the FOXM1\/\u03b2-catenin pathway in glioblastoma","volume":"26","author":"Sun","year":"2023","journal-title":"Neuro-Oncol"},{"key":"10.1016\/j.neuroscience.2026.08.039_b1155","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0273-1177(98)00078-7","article-title":"Correlation between cell death and induction of non-rejoining PCC breaks by carbon-ion beams","volume":"22","author":"Suzuki","year":"1998","journal-title":"Adv. Space Res."},{"key":"10.1016\/j.neuroscience.2026.08.039_b1160","doi-asserted-by":"crossref","first-page":"750","DOI":"10.7150\/jca.101050","article-title":"HIF-1\u03b1 mediated regulation of glioblastoma malignant phenotypes through CD47 protein: understanding functions and mechanisms","volume":"16","author":"Tan","year":"2025","journal-title":"J. Cancer"},{"key":"10.1016\/j.neuroscience.2026.08.039_b1165","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70520","article-title":"Lysine acetyltransferase 6 in health and disease","volume":"6","author":"Tan","year":"2025","journal-title":"MedComm"},{"key":"10.1016\/j.neuroscience.2026.08.039_b1170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41420-022-01286-w","article-title":"ALKBH5 promotes PD-L1-mediated immune escape through m6A modification of ZDHHC3 in glioma","volume":"8","author":"Tang","year":"2022","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.neuroscience.2026.08.039_b1175","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1111\/febs.14777","article-title":"Hyaluronan: molecular size-dependent signaling and biological functions in inflammation and cancer","volume":"286","author":"Tavianatou","year":"2019","journal-title":"FEBS J."},{"key":"10.1016\/j.neuroscience.2026.08.039_b1180","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1200\/EDBK_200819","article-title":"New era in the management of melanoma brain metastases","author":"Tawbi","year":"2018","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"10.1016\/j.neuroscience.2026.08.039_b1185","series-title":"Human Brain and Spinal Cord Tumors: from Bench to Bedside. Volume 1: Neuroimmunology and Neurogenetics","first-page":"51","article-title":"The role of cellular immunity and adaptive immunity in pathophysiology of brain and spinal cord tumors","author":"Tay","year":"2023"},{"key":"10.1016\/j.neuroscience.2026.08.039_b1190","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2020.590034","article-title":"Extracellular vesicles loaded miRNAs as potential modulators shared between glioblastoma, and Parkinson\u2019s and Alzheimer\u2019s diseases","volume":"14","author":"Thomas","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuroscience.2026.08.039_b1195","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.2147\/OTT.S50208","article-title":"Personalized treatment strategies in glioblastoma: MGMT promoter methylation status","volume":"6","author":"Thon","year":"2013","journal-title":"OncoTargets Ther"},{"key":"10.1016\/j.neuroscience.2026.08.039_b1200","doi-asserted-by":"crossref","first-page":"37681","DOI":"10.18632\/oncotarget.16949","article-title":"Modulation of the inwardly rectifying potassium channel Kir4.1 by the pro-invasive miR-5096 in glioblastoma cells","volume":"8","author":"Thuringer","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.neuroscience.2026.08.039_b1205","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/jmri.26171","article-title":"Pseudoprogression of brain tumors","volume":"48","author":"Thust","year":"2018","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.neuroscience.2026.08.039_b1210","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nrc3486","article-title":"Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host","volume":"13","author":"Timp","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.neuroscience.2026.08.039_b1215","doi-asserted-by":"crossref","first-page":"12012","DOI":"10.3390\/ijms241512012","article-title":"Mitochondrial dysfunction associated with mtDNA in metabolic syndrome and obesity","volume":"24","author":"Todosenko","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2026.08.039_b1220","article-title":"Elucidating the mechanisms of temozolomide resistance in gliomas and the strategies to overcome the resistance","volume":"1876","author":"Tomar","year":"2021","journal-title":"Biochim Biophys Acta BBA - Rev Cancer"},{"key":"10.1016\/j.neuroscience.2026.08.039_b1225","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrc2887","article-title":"Targeting the dynamic HSP90 complex in cancer","volume":"10","author":"Trepel","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.neuroscience.2026.08.039_b1230","doi-asserted-by":"crossref","unstructured":"Tripathy DK, Panda LP, Biswal S, Barhwal K (2024) Insights into the glioblastoma tumor microenvironment: current and emerging therapeutic approaches. Front Pharmacol 15 Available at: https:\/\/www.frontiersin.org\/journals\/pharmacology\/articles\/10.3389\/fphar.2024.1355242\/full [Accessed October 20, 2025].","DOI":"10.3389\/fphar.2024.1355242"},{"key":"10.1016\/j.neuroscience.2026.08.039_b1235","doi-asserted-by":"crossref","DOI":"10.1016\/j.prmedi.2025.100052","article-title":"Advances and challenges in personalized diagnosis and therapies for the management of recurrent glioblastoma","volume":"2","author":"Trivedi","year":"2025","journal-title":"Precis Medicat"},{"key":"10.1016\/j.neuroscience.2026.08.039_b1240","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/s41419-024-07003-y","article-title":"Extracellular vesicle-associated DNA: ten years since its discovery in human blood","volume":"15","author":"Tsering","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuroscience.2026.08.039_b1245","doi-asserted-by":"crossref","DOI":"10.1080\/16583655.2025.2479983","article-title":"Mitochondrial DNA depletion promotes vasculogenic properties through mesenchymal alteration in glioblastoma","volume":"19","author":"T\u00fcrksoy Terzio\u011flu","year":"2025","journal-title":"J Taibah Univ Sci"},{"key":"10.1016\/j.neuroscience.2026.08.039_b1250","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.3390\/ijms19041159","article-title":"Conflicting roles of Connexin43 in tumor invasion and growth in the central nervous system","volume":"19","author":"Uzu","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2026.08.039_b1255","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/neuonc\/nov244","article-title":"Directly visualized glioblastoma-derived extracellular vesicles transfer RNA to microglia\/macrophages in the brain","volume":"18","author":"van der Vos","year":"2016","journal-title":"Neuro-Oncol"},{"key":"10.1016\/j.neuroscience.2026.08.039_b1260","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s13046-021-02135-x","article-title":"Differential gene expression-based connectivity mapping identified novel drug candidate and improved temozolomide efficacy for glioblastoma","volume":"40","author":"Vengoji","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.neuroscience.2026.08.039_b1265","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/neuonc\/nos307","article-title":"Differentiating tumor recurrence from treatment necrosis: a review of neuro-oncologic imaging strategies","volume":"15","author":"Verma","year":"2013","journal-title":"Neuro-Oncol"},{"key":"10.1016\/j.neuroscience.2026.08.039_b1270","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.it.2020.06.002","article-title":"The contribution of epigenetics to cancer immunotherapy","volume":"41","author":"Villanueva","year":"2020","journal-title":"Trends Immunol."},{"key":"10.1016\/j.neuroscience.2026.08.039_b1275","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.3390\/ijms22073301","article-title":"The glioblastoma microenvironment: morphology, metabolism, and molecular signature of glial dynamics to discover metabolic rewiring sequence","volume":"22","author":"Virtuoso","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2026.08.039_b1280","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/onc.2017.351","article-title":"Essential role of METTL3-mediated m6A modification in glioma stem-like cells maintenance and radioresistance","volume":"37","author":"Visvanathan","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.neuroscience.2026.08.039_b1285","doi-asserted-by":"crossref","first-page":"5589","DOI":"10.1158\/0008-5472.CAN-21-1606","article-title":"Epigenetic alterations and mechanisms that drive resistance to targeted cancer therapies","volume":"81","author":"Wajapeyee","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.neuroscience.2026.08.039_b1290","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s11060-011-0529-1","article-title":"A multicenter phase I trial of combination therapy with interferon-\u03b2 and temozolomide for high-grade gliomas (INTEGRA study): the final report","volume":"104","author":"Wakabayashi","year":"2011","journal-title":"J. Neurooncol"},{"key":"10.1016\/j.neuroscience.2026.08.039_b1295","article-title":"Tumor-associated microglia and macrophages in glioblastoma: from basic insights to therapeutic opportunities","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuroscience.2026.08.039_b1300","doi-asserted-by":"crossref","first-page":"8363","DOI":"10.3390\/ijms21218363","article-title":"Lactic acid and an acidic tumor microenvironment suppress anticancer immunity","volume":"21","author":"Wang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2026.08.039_b1305","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.2147\/CMAR.S288720","article-title":"Remodelling and treatment of the blood-brain barrier in glioma","volume":"13","author":"Wang","year":"2021","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.neuroscience.2026.08.039_b1310","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3390\/cells15030309","article-title":"Decoding glioblastoma through liquid biopsy: molecular insights and clinical prospects","volume":"15","author":"Wasiak","year":"2026","journal-title":"Cells"},{"key":"10.1016\/j.neuroscience.2026.08.039_b1315","doi-asserted-by":"crossref","DOI":"10.1093\/neuonc\/noac209.1112","article-title":"Lathia JTMIC-69. Mitochondrial transfer from astrocytes enhances metabolism and drives proliferation of glioblastoma","volume":"24","author":"Watson","year":"2022","journal-title":"Neuro-Oncol"},{"key":"10.1016\/j.neuroscience.2026.08.039_b1320","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/s43018-023-00556-5","article-title":"GAP43-dependent mitochondria transfer from astrocytes enhances glioblastoma tumorigenicity","volume":"4","author":"Watson","year":"2023","journal-title":"Nat Cancer"},{"key":"10.1016\/j.neuroscience.2026.08.039_b1325","doi-asserted-by":"crossref","unstructured":"Watson DC, Bayik D, Williford SE, Lauko A, Zhou Y, Deshpande G, Seder J, Mears JA, Cheng F, Hjelmeland AB, Lathia JD (2021) Horizontal mitochondrial transfer from the microenvironment increases glioblastoma tumorigenicity. :2021.09.01.458565 Available at: https:\/\/www.biorxiv.org\/content\/10.1101\/2021.09.01.458565v1 [Accessed July 28, 2026].","DOI":"10.1101\/2021.09.01.458565"},{"key":"10.1016\/j.neuroscience.2026.08.039_b1330","doi-asserted-by":"crossref","DOI":"10.1016\/j.stemcr.2025.102507","article-title":"How neural stem cell therapy promotes brain repair after stroke","volume":"20","author":"Weber","year":"2025","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.neuroscience.2026.08.039_b1335","doi-asserted-by":"crossref","unstructured":"Wei C, Wang B, Peng D, Zhang X, Li Z, Luo L, He Y, Liang H, Du X, Li S, Zhang S, Zhang Z, Han L, Zhang J (2022) Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas. Front Immunol 13 Available at: https:\/\/www.frontiersin.org\/journals\/immunology\/articles\/10.3389\/fimmu.2022.849592\/full [Accessed June 27, 2024].","DOI":"10.3389\/fimmu.2022.944740"},{"key":"10.1016\/j.neuroscience.2026.08.039_b1340","doi-asserted-by":"crossref","DOI":"10.1093\/neuonc\/noab196.217","article-title":"CTIM-25. A randomized PHASE 3 study of nivolumab or placebo combined with radiotherapy plus temozolomide in patients with newly diagnosed glioblastoma with methylated MGMT promoter: checkmate 548","volume":"23","author":"Weller","year":"2021","journal-title":"Neuro-Oncol"},{"key":"10.1016\/j.neuroscience.2026.08.039_b1345","doi-asserted-by":"crossref","first-page":"ii73","DOI":"10.1093\/neuonc\/noac174.254","article-title":"P11.65.B GBM AGILE: a global, phase 2\/3 adaptive platform trial to evaluate multiple treatment regimens in newly diagnosed and recurrent glioblastoma","volume":"24","author":"Weller","year":"2022","journal-title":"Neuro-Oncol"},{"key":"10.1016\/j.neuroscience.2026.08.039_b1350","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1200\/JCO-25-01137","article-title":"Evaluation of regorafenib in newly diagnosed and recurrent glioblastoma: GBM AGILE phase II\/III bayesian randomized platform trial","volume":"44","author":"Wen","year":"2026","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.neuroscience.2026.08.039_b1355","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1200\/JCO.2009.26.3541","article-title":"Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group","volume":"28","author":"Wen","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.neuroscience.2026.08.039_b1360","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1186\/s12967-024-05301-9","article-title":"The tumour microenvironment, treatment resistance and recurrence in glioblastoma","volume":"22","author":"White","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.neuroscience.2026.08.039_b1365","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1146\/annurev-pharmtox-011112-140326","article-title":"Cause and consequence of cancer\/testis antigen activation in cancer","volume":"54","author":"Whitehurst","year":"2014","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuroscience.2026.08.039_b1370","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nrc1716","article-title":"HSP90 and the chaperoning of cancer","volume":"5","author":"Whitesell","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.neuroscience.2026.08.039_b1375","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2020.100729","article-title":"The key roles of the lysine acetyltransferases KAT6A and KAT6B in physiology and pathology","volume":"53","author":"Wiesel-Motiuk","year":"2020","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.neuroscience.2026.08.039_b1380","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.humimm.2022.01.014","article-title":"The acidic tumour microenvironment: manipulating the immune response to elicit escape","volume":"83","author":"Worsley","year":"2022","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.neuroscience.2026.08.039_b1385","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.3390\/ijms26072907","article-title":"Reactive astrocytes in glioma: emerging opportunities and challenges","volume":"26","author":"Wu","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2026.08.039_b1390","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105780","article-title":"Glioblastoma multiforme (GBM): an overview of current therapies and mechanisms of resistance","volume":"171","author":"Wu","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuroscience.2026.08.039_b1395","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/neuonc\/nov171","article-title":"Tumor microenvironment tenascin-C promotes glioblastoma invasion and negatively regulates tumor proliferation","volume":"18","author":"Xia","year":"2015","journal-title":"Neuro-Oncol"},{"key":"10.1016\/j.neuroscience.2026.08.039_b1400","doi-asserted-by":"crossref","first-page":"584","DOI":"10.17305\/bb.2022.8562","article-title":"Increased co-expression of TIM-3 with TIGIT or 2B4 on CD8+ T cells is associated with poor prognosis in locally advanced nasopharyngeal carcinoma","volume":"23","author":"Xie","year":"2023","journal-title":"Biomol Biomed"},{"key":"10.1016\/j.neuroscience.2026.08.039_b1405","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41392-025-02325-5","article-title":"Dual roles and therapeutic targeting of tumor-associated macrophages in tumor microenvironments","volume":"10","author":"Xu","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.neuroscience.2026.08.039_b1410","article-title":"HSP90B1 facilitates glioma radiotherapy resistance by regulating RhoC ubiquitin\u2012proteasome degradation","volume":"13","author":"Xu","year":"2026","journal-title":"Genes Dis"},{"key":"10.1016\/j.neuroscience.2026.08.039_b1415","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1007\/s10571-022-01283-8","article-title":"The critical role of RNA m6A methylation in gliomas: targeting the hallmarks of cancer","volume":"43","author":"Xu","year":"2022","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.neuroscience.2026.08.039_b1420","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/neuonc\/noab269","article-title":"Cancer cell heterogeneity and plasticity: a paradigm shift in glioblastoma","volume":"24","author":"Yabo","year":"2022","journal-title":"Neuro-Oncol"},{"key":"10.1016\/j.neuroscience.2026.08.039_b1425","doi-asserted-by":"crossref","unstructured":"Yan D, Adeshakin AO, Xu M, Afolabi LO, Zhang G, Chen YH, Wan X (2019) Lipid Metabolic Pathways Confer the Immunosuppressive Function of Myeloid-Derived Suppressor Cells in Tumor. Front Immunol 10 Available at: https:\/\/www.frontiersin.org\/journals\/immunology\/articles\/10.3389\/fimmu.2019.01399\/full [Accessed December 9, 2024].","DOI":"10.3389\/fimmu.2019.01399"},{"key":"10.1016\/j.neuroscience.2026.08.039_b1430","article-title":"Liquid biopsy strategies to distinguish progression from pseudoprogression and radiation necrosis in glioblastomas","volume":"4","author":"Yekula","year":"2020","journal-title":"Adv. Biosyst."},{"key":"10.1016\/j.neuroscience.2026.08.039_b1435","first-page":"1","article-title":"The role of extracellular vesicles in acquisition of resistance to therapy in glioblastomas","volume":"4","author":"Yekula","year":"2021","journal-title":"Cancer Drug Resist"},{"key":"10.1016\/j.neuroscience.2026.08.039_b1440","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ebiom.2019.03.016","article-title":"Exosomal transfer of miR-1238 contributes to temozolomide-resistance in glioblastoma","volume":"42","author":"Yin","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.neuroscience.2026.08.039_b1445","unstructured":"Yin M, Guo L (2025) Mitochondrial DNA methylation: State-of-the-art in molecular mechanisms and disease implications. J Adv Res Available at: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2090123225006447 [Accessed April 7, 2026]."},{"key":"10.1016\/j.neuroscience.2026.08.039_b1450","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s10555-023-10114-1","article-title":"The role of histone H3 lysine demethylases in glioblastoma","volume":"42","author":"Young","year":"2023","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.neuroscience.2026.08.039_b1460","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1148\/radiol.14132632","article-title":"Glioblastoma treated with concurrent radiation therapy and temozolomide chemotherapy: differentiation of true progression from pseudoprogression with quantitative dynamic contrast-enhanced MR imaging","volume":"274","author":"Yun","year":"2015","journal-title":"Radiology"},{"key":"10.1016\/j.neuroscience.2026.08.039_b1465","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pbiomolbio.2025.05.003","article-title":"Advances in the mechanisms of HIF-1\u03b1-enhanced tumor glycolysis and its relation to dedifferentiation","volume":"197","author":"Zeng","year":"2025","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"10.1016\/j.neuroscience.2026.08.039_b1470","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174177","article-title":"EZH2 regulates the malignancy of human glioblastoma cells via modulation of twist mRNA stability","volume":"904","author":"Zhai","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuroscience.2026.08.039_b1475","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s40364-025-00788-w","article-title":"Epigenetic regulation of histone modifications in glioblastoma: recent advances and therapeutic insights","volume":"13","author":"Zhang","year":"2025","journal-title":"Biomark Res"},{"key":"10.1016\/j.neuroscience.2026.08.039_b1480","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2023.111016","article-title":"Cancer-associated fibroblasts-induced remodeling of tumor immune microenvironment via Jagged1 in glioma","volume":"115","author":"Zhang","year":"2024","journal-title":"Cell. Signal."},{"key":"10.1016\/j.neuroscience.2026.08.039_b1485","doi-asserted-by":"crossref","first-page":"11233","DOI":"10.3390\/ijms241411233","article-title":"Innate immunity in cancer biology and therapy","volume":"24","author":"Zhang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2026.08.039_b1490","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.7150\/ijbs.125306","article-title":"HAT1 as a lactyltransferase to promote DNA repair through RPA1 lactylation in glioblastoma","volume":"22","author":"Zhao","year":"2026","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.neuroscience.2026.08.039_b1495","first-page":"460","article-title":"The mechanisms and clinical significance of CD8+ T cell exhaustion in anti-tumor immunity","volume":"22","author":"Zhong","year":"2025","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.neuroscience.2026.08.039_b1500","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s10555-025-10276-0","article-title":"Astrocyte involvement in brain metastasis: from biological mechanisms to therapeutic strategies","volume":"44","author":"Zhou","year":"2025","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.neuroscience.2026.08.039_b1505","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.7150\/ijbs.45420","article-title":"How DNA methylation affects the Warburg effect","volume":"16","author":"Zhu","year":"2020","journal-title":"Int. J. Biol. Sci."}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452226005828?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452226005828?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:27:37Z","timestamp":1790771257000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452226005828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":295,"alternative-id":["S0306452226005828"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2026.08.039","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting glioblastoma epigenetics: mechanisms, microenvironmental interplay, and therapeutic potential","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2026.08.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Brain Research Organization (IBRO). Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}